DROSPIRENONE WITH ETHINYLESTRADIOL

Brand name:

• Yaz®
• Yasmin®

Pharmaceutical company:

BAYER AUSTRALIA LTD

Condition/indication:
(therapeutic use)

• Oral contraceptive Moderate acne vulgaris in women who seek oral contraception Premenstrual dysphoric disorder in women who have chosen oral contraceptives as their method of birth control

PBAC Submission type:

New listing (–)

Comment:

--

Public Summary Document:

Not yet available

Related medicines:

• DROSPIRENONE WITH ETHINYLESTRADIOL

Submission received for:

November 2024 PBAC meeting

Opportunity for consumer comment:

Open 31/07/2024 and close 25/09/2024 (see PBS Website)

PBAC meeting:

Held on 06/11/2024

PBAC outcome published:

Recommended (see PBAC Outcomes)

Notice of intent submitted:

04/12/2024

Lodgement of required documentation:

11/12/2024

Acceptance of complete documentation:

Accepted

Agreement to listing arrangements:

Commenced on 19/12/2024

Status:

Finalised

Government processes:

Commenced on 10/01/2025

Medicine listed on the PBS:

01/03/2025 (see PBS schedule)

---